This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove CBD Remove Compliance Remove Nerve Pain Related Topics
Compliance Clinical Trials Treatment Epilepsy Patients Chronic Pain Decriminalization Collective Consumption Safety More Related Topics >
article thumbnail

‘Too costly, not enough evidence it works’, says UK in blow to cannabis campaigners

Cannabis Law Report

AUGUST 21, 2019

THC (delta-9-Tetrahydracannabinol) and CBD (cannabidiol) are the two elements that have been most investigated for their medicinal value. The draft NICE guideline also does not recommend the use of cannabis-based medicinal products for people with chronic pain, including people with MS experiencing nerve pain.

Clinical Trials 81
Clinical Trials Nerve Pain Medicine Epilepsy 81
article thumbnail

The Green Wave – Legal Challenges, Considerations for Investors in Cannabis Industry

Cannabis Law Report

MARCH 19, 2020

Marijuana or cannabis can be used to treat a multitude of diseases; more importantly, it is known to be effective in reducing pain. It is imperative that cannabis businesses adhere to stringent legal compliance and steer clear of any likely illegalities with respect to the cannabis business.

Legalization 59
Legalization Banking Research and Development Nerve Pain 59
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024